Hepatocyte labeling with 99msTc-GSA: A potential non-invasive technique for tracking cell transplantation

International Journal of Artificial Organs

Volumn 35, Issue 6, 2012, Pages 450-457

  Chouhan, Manil ^a   Puppi, Juliana ^a   Solanas, Estela ^a   Mitry, Ragai R ^a   Dhawan, Anil ^a   Hughes, Robin D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Asialoglycoprotein receptor; Cell labeling; Galactosyl serum albumin; Hepatocytes; Radioactive technetium; Transplantation

Indexed keywords

BODY FLUIDS; CELLS; CYTOLOGY; RATS; TECHNETIUM;

ASIALOGLYCOPROTEIN RECEPTORS; CELL LABELLING; GALACTOSYL SERUM ALBUMIN; HEPATOCYTES; HUMAN HEPATOCYTES; LABELINGS; RADIOACTIVE TECHNETIUM; SERUM ALBUMIN; TECHNETIUM-; TRANSPLANTATION;

MOLECULAR BIOLOGY;

GALACTOSE; HUMAN SERUM ALBUMIN; RADIOLIGAND; SULFORHODAMINE B; TECHNETIUM 99M; ASIALOGLYCOPROTEIN RECEPTOR; DIAGNOSTIC AGENT; MACROSALB TC 99M; PENTETATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM TC 99M DTPA GALACTOSYL HUMAN SERUM ALBUMIN; TECHNETIUM TC 99M DTPA-GALACTOSYL-HUMAN SERUM ALBUMIN;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL TRACKING; CELL TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; ENDOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; ISOTOPE LABELING; LIVER CELL; MALE; NON INVASIVE PROCEDURE; NONHUMAN; RADIOACTIVITY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPERATURE; ANIMAL; CELL CULTURE; CELL SURVIVAL; GENETICS; METABOLISM; METHODOLOGY; SCINTISCANNING; SPRAGUE DAWLEY RAT; TIME; TRANSPLANTATION; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ASIALOGLYCOPROTEIN RECEPTOR; BIOLOGICAL TRANSPORT; CELL SURVIVAL; CELL TRACKING; CELLS, CULTURED; CRYOPRESERVATION; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE; TEMPERATURE; TIME FACTORS;

EID: 84863753311     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000096     Document Type: Article

References (41)

1. Dhawan A, Mitry RR, Hughes RD. Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis. 2006;29:431-435.
2. Fisher RA, Strom SC. Human hepatocyte transplantation: worldwide results. Transplantation. 2006;82:441-449.
3. Smets F, Najimi M, Sokal EM. Cell transplantation in the treatment of liver diseases. Pediatr Transplant. 2008;12:6-13.
4. Dhawan A, Puppi J, Hughes RD, Mitry RR. Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol. 2010;7:288-298.
5. Dhawan A, Mitry RR, Hughes RD, et al. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation. 2004;78:1812-1814.
6. Puppi J, Tan N, Mitry RR, et al. Hepatocyte transplantation followed by auxiliary liver transplantation - a novel treatment for ornithine transcarbamylase deficiency. Am J Transplant. 2008;8:452-457.
7. Strom SC, Chowdhury JR, Fox IJ. Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis. 1999;19:39-48.
8. Quaglia A, Lehec SC, Hughes RD, et al. Liver after hepatocyte transplantation for liver-based metabolic disorders in children. Cell Transplant. 2008;17:1403-1414.
9. Mas VR, Maluf DG, Thompson M, Ferreira-Gonzalez A, Fisher RA. Engraftment measurement in human liver tissue after liver cell transplantation by short tandem repeats analysis. Cell Transplant. 2004;13:231-236.
10. Stéphenne X, Najimi M, Sibille C, et al. Sustained engraft-ment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology. 2006;130:1317-1323.
11. Gupta S, Rajvanshi P, Sokhi R, et al. Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium. Hepatology. 1999;29:509-519.
12. Kokudo N, Vera DR, Makuuchi M. Clinical application of TcGSA. Nucl Med Biol. 2003;30:845-849.
13. 99mTc]galactosyl-neoglycoalbumin. Dig Dis Sci. 1993;38:2183-2188.
14. Vera DR, Stadalnik RC, Krohn KA. Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies. J Nucl Med. 1985;26:1157-1167.
15. Yoshida H, Mamada Y, Taniai N, et al. Simultaneous evaluation of portal hemodynamics and liver function by scintiphoto-splenoportography in pediatric recipients of living-donor liver transplants. Hepatogastroenterology. 2009;56:819-823.
16. 99mTc-neoglycosylated human serum albumins. Arch Pharm Res. 2008;31:60-66.
17. Weigel PH. Endocytosis and function of the hepatic asialoglyco-protein receptor. Subcell Biochem. 1993;19:125-161.
18. Casey CA, Lee SM, Aziz-Seible R, Mcvicker BL. Impaired receptor-mediated endocytosis: its role in alcohol-induced apoptosis. J Gastroenterol Hepatol. 2008;23(Suppl 1):S46-S4.
19. Dalton SR, Lee SM, King RN, et al. Carbon tetrachloride-induced liver damage in asialoglycoprotein receptor-deficient mice. Bio-chem Pharmacol. 2009;77:1283-1290.
20. Lee SM, Casey CA, McVicker BL. Impact of asialoglycoprotein receptor deficiency on the development of liver injury. World J Gastroenterol. 2009;15:1194-1200.
21. Pimstone NR, Stadalnik RC, Vera DR, Hutak D P, Trudeau WL. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog. Hepatology. 1994;20:917-923.
22. Stockert RJ. The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol Rev. 1995;75:591-609.
23. Mitry RR, Hughes RD, Aw MM, et al. Human hepatocyte isolation and relationship of cell viability to early graft function. Cell Transplant. 2003;12:69-74.
24. Diener B, Utesch D, Beer N, Durk H, Oesch F. A method for the cryopreservation of liver parenchymal cells for studies of xeno-biotics. Cryobiology. 1993;30:116-127.
25. Terry C, Dhawan A, Mitry RR, Lehec SC, Hughes RD. Optimization of the cryopreservation and thawing protocol for human hepatocytes for use in cell transplantation. Liver Transpl. 2010;16:229-237.
26. Steinberg P, Fischer T, Kiulies S, et al. Drug metabolizing capacity of cryopreserved human, rat, and mouse liver parenchymal cells in suspension. Drug Metab Dispos. 1999;27:1415-1422.
27. Reese JA, Byard JL. Isolation and culture of adult hepatocytes from liver biopsies. In Vitro. 1981;17:935-940.
28. Weigel PH, Yik JH. Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors. Biochim Biophys Acta. 2002;1572:341-363.
29. Zvibel I, Smets F, Soriano H. Anoikis: roadblock to cell transplantation? Cell Transplant. 2002;11:621-630.
30. Terry C, Mitry RR, Lehec SC, et al. The effects of cryopreserva-tion on human hepatocytes obtained from different sources of liver tissue. Cell Transplant. 2005;14:585-594.
31. Terry C, Dhawan A, Mitry RR, Hughes RD. Cryopreservation of isolated human hepatocytes for transplantation: State of the art. Cryobiology. 2006;53:149-159.
32. 99mTC or endogenous dipeptidyl peptidase IV activity. Cell Transplant. 1997;6:377-386.
33. Costa DC, Ell PJ, Cullum ID, Jarritt PH. The in vivo distribution of 99Tcm-HM-PAO in normal man. Nucl Med Commun. 1986;7:647-658.
34. Cheng K, Benten D, Bhargava K, et al. Hepatic targeting and biodistribution of human fetal liver stem/progenitor cells and adult hepatocytes in mice. Hepatology. 2009;50:1194-1203.
35. Bohnen NI, Charron M, Reyes J, et al. Use of indium-111-la-beled hepatocytes to determine the biodistribution of transplanted hepatocytes through portal vein infusion. Clin Nucl Med. 2000;25:447-450.
36. Puppi J, Mitry RR, Modo M, et al. Use of a clinically approved iron oxide MRI contrast agent to label human hepatocytes. Cell Transplant. 2011;20:963-975.
37. Terry C, Hughes RD, Mitry RR, Lehec SC, Dhawan A. Cryo-preservation-induced nonattachment of human hepatocytes: role of adhesion molecules. Cell Transplant. 2007;16:639-647.
38. Kaibori M, Ha-Kawa SK, Uchida Y, et al. Liver regeneration in donors evaluated by Tc-99m-GSA scintigraphy after living donor liver transplantation. Dig Dis Sci. 2008;53:850-855.
39. Kwon AH, Matsui Y, Kaibori M, Ha-Kawa SK. Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection. Surgery. 2006;140:379-386.
40. Kwon AH, Matsui Y, Kaibori M, Kamiyama Y. Functional hepatic regeneration following hepatectomy using galactosyl-human serum albumin liver scintigraphy. Transplant Proc. 2004;36:2257-2260.
41. Shuke N, Okizaki A, Kino S, et al. Functional mapping of regional liver asialoglycoprotein receptor amount from single blood sample and SPECT. J Nucl Med. 2003;44:475-482.